[go: up one dir, main page]

DK1349578T3 - Kombinationspræparat indeholdende en biguanin (metformin) og arginin - Google Patents

Kombinationspræparat indeholdende en biguanin (metformin) og arginin

Info

Publication number
DK1349578T3
DK1349578T3 DK01990621T DK01990621T DK1349578T3 DK 1349578 T3 DK1349578 T3 DK 1349578T3 DK 01990621 T DK01990621 T DK 01990621T DK 01990621 T DK01990621 T DK 01990621T DK 1349578 T3 DK1349578 T3 DK 1349578T3
Authority
DK
Denmark
Prior art keywords
biguanine
metformin
arginine
preparation containing
combination preparation
Prior art date
Application number
DK01990621T
Other languages
Danish (da)
English (en)
Inventor
Dominique Halbitte
Jean-Robert Rapin
Original Assignee
Inopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inopharm filed Critical Inopharm
Application granted granted Critical
Publication of DK1349578T3 publication Critical patent/DK1349578T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01990621T 2000-12-29 2001-12-31 Kombinationspræparat indeholdende en biguanin (metformin) og arginin DK1349578T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0017332A FR2818906B1 (fr) 2000-12-29 2000-12-29 Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine

Publications (1)

Publication Number Publication Date
DK1349578T3 true DK1349578T3 (da) 2006-11-27

Family

ID=8858430

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01990621T DK1349578T3 (da) 2000-12-29 2001-12-31 Kombinationspræparat indeholdende en biguanin (metformin) og arginin

Country Status (15)

Country Link
US (2) US7265156B2 (ja)
EP (1) EP1349578B1 (ja)
JP (1) JP4477301B2 (ja)
AT (1) ATE333901T1 (ja)
CA (1) CA2435484A1 (ja)
CY (1) CY1105736T1 (ja)
DE (1) DE60121804T2 (ja)
DK (1) DK1349578T3 (ja)
ES (1) ES2271103T3 (ja)
FR (1) FR2818906B1 (ja)
NZ (1) NZ527206A (ja)
PT (1) PT1349578E (ja)
RU (1) RU2003123491A (ja)
WO (1) WO2002053090A2 (ja)
ZA (1) ZA200207761B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
KR101541791B1 (ko) 2006-05-04 2015-08-04 베링거 인겔하임 인터내셔날 게엠베하 다형태
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CA2776296C (en) 2009-10-02 2017-11-07 Boehringer Ingelheim International Gmbh Therapeutic uses of pharmaceutical compositions
WO2011051974A1 (en) * 2009-10-29 2011-05-05 Nutracryst Therapeutics Private Limited Metformin and a-amino acids
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US20120178813A1 (en) * 2011-01-12 2012-07-12 Thetis Pharmaceuticals Llc Lipid-lowering antidiabetic agent
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP4151218A1 (en) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
CN105277705A (zh) * 2014-07-24 2016-01-27 江苏维赛科技生物发展有限公司 一种检测双胍类药物残留的试剂盒的制备及其检测方法
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2037002A1 (en) 1969-04-30 1970-12-31 Roques Bernard N-substd biguanide pamoic acid salts prepn
FR2696740B1 (fr) * 1992-10-13 1994-12-30 Dospharma Sa Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
ES2216335T3 (es) * 1997-12-08 2004-10-16 Bristol-Myers Squibb Company Nuevas sales de metformina y procedimiento.
EP1063973B1 (en) * 1998-03-19 2016-11-16 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
AU3536299A (en) * 1998-04-29 1999-11-16 Sumitomo Pharmaceuticals Company, Limited Oral formulation comprising biguanide and an organic acid
FR2796551B1 (fr) 1999-07-23 2003-07-25 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
AU2001213150A1 (en) 2000-08-03 2002-02-18 Olga Evgenievna Kolesova Composition of metformin with succinic acid or salts thereof and method for treating diabetes

Also Published As

Publication number Publication date
EP1349578B1 (fr) 2006-07-26
WO2002053090A3 (fr) 2003-02-20
PT1349578E (pt) 2006-12-29
US20040097399A1 (en) 2004-05-20
ES2271103T3 (es) 2007-04-16
CY1105736T1 (el) 2010-12-22
RU2003123491A (ru) 2005-01-10
JP4477301B2 (ja) 2010-06-09
ATE333901T1 (de) 2006-08-15
CA2435484A1 (fr) 2002-07-11
JP2004517105A (ja) 2004-06-10
FR2818906A1 (fr) 2002-07-05
ZA200207761B (en) 2004-05-28
DE60121804T2 (de) 2007-08-23
US20070265349A1 (en) 2007-11-15
FR2818906B1 (fr) 2004-04-02
DE60121804D1 (de) 2006-09-07
US7265156B2 (en) 2007-09-04
NZ527206A (en) 2006-12-22
EP1349578A2 (fr) 2003-10-08
WO2002053090A2 (fr) 2002-07-11

Similar Documents

Publication Publication Date Title
DK1349578T3 (da) Kombinationspræparat indeholdende en biguanin (metformin) og arginin
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
YU5503A (sh) Nesteroidni supresori zapaljenja
DK1200418T3 (da) Nematodicide trifluorbutener
SE0002102D0 (sv) Chemical compound
NO20034660D0 (no) Spiropyrazolforbindelser
NO20035603D0 (no) Fluorpyrrolidiner som dipeptidyl peptidase inhibitorer
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
AR044706A2 (es) Procedimientos para preparar 4-aminoquinolinas, inhibidores de cetp
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
MXPA03009602A (es) Analogos de nociceptina.
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
AU1142502A (en) Novel crystalline forms of a factor xa inhibitor
SE0201938D0 (sv) New process
ATE254099T1 (de) Trimethyldecen-verbindungen
ATE242763T1 (de) Methoximinophenylessigsäureamide
ATE328602T1 (de) Kombinationspräparat zur behandlung des diabetes mellitus
NO20055582L (no) Preparater og fremgangsmater omfattende gastrinforbindelser
PL365687A1 (en) Novel trioxepan compounds
MXPA03003466A (es) Derivados de piranosido.
DE50100533D1 (de) Herstellung von 2-ethyl-3-methyl-1,4-diazin
PL356931A1 (pl) Zastosowanie naturalnych związków mających aktywność przeciwnaczyniotwórczą
MXPA04002400A (es) Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.
DK1131273T3 (da) 1,4-Diaryl-2-fluor-1-buten-3-olforbindelser og deres anvendelse til fremstilling af 1,4-diaryl-2-fluor-1,3-butadien- og 1,4-diaryl-2-fluor-2-butenforbindelser
WO2002023784A3 (en) Cysteine protease inhibitors